View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Rituximab 500 / bendamustine 90, Chronic Lymphocytic Leukemia, first-line, cycle 2-6
Protocol-ID: 316 V1.0 (Mini), R-BENDA (RITU500/BEND90), CLL, first-line, C2-6Indication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
Links
- Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 29.12.2014